NCT03085875 POWERMOM, A Healthy Pregnancy Research Community
| NCT ID | NCT03085875 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Scripps Translational Science Institute |
| Condition | Pregnancy Related |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2017-03-16 |
| Primary Completion | 2027-03-13 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2017-03-16 with a primary completion date of 2027-03-13.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will take advantage of the open source framework of ResearchKit developed by Apple to bring research directly to participants. Using the ResearchKit platform as well as a stand alone app available for Android and HTML, it makes it easier to enroll large numbers of participants and carry out real-world health research to answer questions important to a broad population.
Eligibility Criteria
Inclusion Criteria: * Adults, 16 years of age or older * Pregnant women or within 8 weeks postpartum * Currently live within the United States * Own, and comfortable using, a smartphone or tablet Exclusion Criteria: • Inability to consent
Contact & Investigator
Lase Ajayi, MD
PRINCIPAL INVESTIGATOR
The Scripps Research Institute
Frequently Asked Questions
Who can join the NCT03085875 clinical trial?
This trial is open to female participants only, aged 16 Years or older, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03085875 currently recruiting?
Yes, NCT03085875 is actively recruiting participants. Contact the research team at tajayi@scripps.edu for enrollment information.
Where is the NCT03085875 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT03085875 clinical trial?
NCT03085875 is sponsored by Scripps Translational Science Institute. The principal investigator is Lase Ajayi, MD at The Scripps Research Institute. The trial plans to enroll 100,000 participants.